OraSure Technologies, Inc.(OSUR) stock price and fundamentals

Medical - Instruments & Supplies · Bethlehem, PA

$3.87-0.24 (-5.84%)

Delayed quote: Oct 6, 2026, 12:25 PM EDT

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1OSUR	$266.44M	$3.87	-5.84%	+29.09%	-17.56%	-6.51%	N/A
2EPRX	$266.50M	$7.96	+2.78%	+32.30%	N/A	N/A	vs OSUR
3IKT	$266.05M	$2.02	+0.75%	+20.37%	-29.10%	N/A	vs OSUR
4EYPT	$267.03M	$3.19	+1.11%	-76.90%	-21.68%	-20.02%	vs OSUR
5LXEO	$263.05M	$3.35	-1.76%	-48.33%	N/A	N/A	vs OSUR
6PALI	$261.24M	$1.50	+3.08%	-8.78%	-76.02%	-71.24%	vs OSUR

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.23	$-0.23	$-0.23	1
Quarter ending Dec 2026	$-0.20	$-0.20	$-0.20	1
Quarter ending Mar 2027	$-0.21	$-0.21	$-0.21	1
Quarter ending Jun 2027	$-0.20	$-0.20	$-0.20	1

Period	Low	Avg	High	# Analysts
FY 2026	$-0.66	$-0.66	$-0.66	1
FY 2027	$-0.81	$-0.81	$-0.81	1

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$31.14M	$31.14M	$31.14M	1
Quarter ending Dec 2026	$32.40M	$32.40M	$32.40M	1
Quarter ending Mar 2027	$30.24M	$30.24M	$30.24M	1
Quarter ending Jun 2027	$34.66M	$34.66M	$34.66M	1

FY 2026	$122.11M	$122.11M	$122.11M	1
FY 2027	$133.20M	$133.20M	$133.20M	1

OraSure Technologies, Inc.(OSUR) stock price and fundamentals

Valuation

Yields

OSUR Price Chart

Business at a glance

OSUR Key Metrics

Total Return CAGR

OSUR Fundamental Charts

Revenue CAGR

OSUR Selected Revenue Disclosures

Product / business disclosures (FY 2025)

Geographic disclosures (FY 2025)

OSUR Earnings Preview

Similar-Size Sector Stocks

OSUR Competitors' Key Metrics

OSUR Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

OSUR Analyst Ratings

OSUR Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates